Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BS3003 > 8th March - Endogenous inhibitors of angiogenesis > Flashcards

8th March - Endogenous inhibitors of angiogenesis Flashcards

1
Q

What was the first endogenous negative regulator of angiogenesis to be discovered?

A

Angiostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the different effects of angiostatin at the primary tumour and at a distant site?

A

Angiostatin –> short half lives - bFGF and VEGF, long half lives - inhibitors

At primary tumour site - positive stimulus > negative stimulus
At secondary tumour site - negative stimulus > positive stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the lewis lung tumour model?

A

that the primary subcutenous tumour –| lung metastases growth to less than 200µm diameter

Removal of the primary tumour led to rapid lung metastatic growth as they became angiogenic

–> Tumour is suppressing metastases

Serum/urine from tumour bearing mice –| metastatic growth therefore the inhibitor is present in either serum or urine of the tumour bearing mouse

Serum/urine of tumour bearing mouse –| capillary endothelial cell proliferation in culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How was angiostatin purified?

A

18l urine from tumour bearing mice –> dialysis –> heparin-sepharose chromatography –> bio-gel A 0.5 m, agarose chromatography –> HPLC/C4 reverse phase chromatography –> 1327X purifcation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is angiostatin?

A

A 38kDa fragment of plasminogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How was the function of angiostatin verified?

A

It was injected into mice which had their initial tumour removed, found it specifically inhibits growing vascular endothelial cells

Inhibited primary tumour growth by up to 98%
Caused regression of large tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is angiostatin secreted by the tumour?

A

No the tumour releases uPA and MMp which cleave plasminogen to form angiostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the structure of plasminogen?

A

5 kringle domains held together by disulphide bonds
K1-K3 is sufficient to provide the anti-angiogenic nature of angiostatin
K5 is the plasmin catalytic domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is angiostatins proposed mechanism of action?

A

Inhibits F1Fo ATPase activity which is required for endothelial cell survival under pH stress inherent int he tumour microenvironment

Binds to angiomotin which inhibits endothelial cell migration, invasion and morphogenesis

Binds to alphavbeta3 integrin which antagonizes the proliferative, migratory and pro-survival signals mediated by integrin-matrix interaction

Binds to c-Met decreases activation of PI3K/Akt leading to release of suppression of apoptosis and blocking of cell cycle progression into S-phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the basement membrane derived inhibitors of angiogenesis?

A 
Endostatin 
Restin 
Arrestin 
Canstatin
Tumstatin
alpha6 NCI domain
Endorepellin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the receptors for endostatin?

A

alpha 5 beta 1 integrin, VEGFR2, glycipin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the receptor for arrestin?

A

alpha 1 beta1 integrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the receptor for tumstatin?

A

alphavbeta3 integrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the receptor for endorepellin?

A

alpha 2 beta 1 integrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who discovered endostatin in 1997?

A

O’reilly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is endostatin?

A

A 20kDa fragment of collagen XVII which is a cryptic angiogenesis inhibitor

17
Q

What happens when endostatin is applied to a tumour?

A

It increases the apoptosis rate 7x and has no effect on proliferation

18
Q

What is the function of glypican?

A

It binds endostatin to the endothelial cell surface

19
Q

What are the molecular responses to endostatin?

A

Inhibition of VEGF121, VEGF165, VEGFR2 –> reduced endothelial cell survival and proliferation

Inhibition of MMPs –> reduced endothelial cell invasion

Inhibition of VEGF driven relocalisation of Beta catenin from cell-cell junctions –> Maintains endothelial cell-cell adhesion

Binds alpha5 beta1 integrin preventing integrin dependent epithelial cell migration

Downregulates cyclin D2 –> G1 arrest in endothelial cells

Inhibits PDGF mediated recruitment of peri-vascular cells

20
Q

Describe the use of endostatin in cancer therapy

A

Daily administration of endostatin suppressed lewis lung primary tumour growth

As endostatin is aimed at genomically stable endothelial cells they are less likely to develop resistance by mutation

21
Q

What is thrombospondin?

A

A 140kDa fragment of TSp-1 which inhibits angiogenesis

22
Q

How is thrombospondin expression related to angiogenic activity?

A

It is inversely proportional

23
Q

How is thrombospondin expression regulated?

A

By WT p53 in fibroblasts and mammary epithelial cells

24
Q

What effect does a loss of p53 have on thrombospondin levels?

A

Dramatic decrease in TSP-1

25
Q

What is the function of type 1 repeats in thrombospondin?

A

Inhibits angiogenesis
Induces apoptosis
Binds CD36

ANTI-ANGIOGENIC ACTIVITY IS RESTRICTED TO TYPE I REPEATS

26
Q

Describe the findings of Jiminez (2000)

A

Performed a corneal pocket assay in a mouse
Found that signalling molecules induces by TSP-1 in microvascular endothelial cells were essential for angiogenesis inhibition. This is dependent on CD36, p59 Fyn, caspase 3 and p38.

27
Q

What is the mechanism of TSP1?

A
  1. TSP1 binds to CD36 receptor on neighbouring endothelial cell
  2. Activates p59 fyn
  3. Activates p38, JNK
  4. Activates transcription
  5. Transmitted through Fas receptor to neighbouring cell
  6. Activates caspases
  7. Triggers cell death
28
Q

What are the advantages of targeting angiogenesis in cancer therapy?

A

Endothelial cells are genetically stable therefore less chance of resistance developing
Not restricted to certain histological tumours
Tumour microvasculature is easily accessible
In adult organisms angiogenesis is only induced under certain conditions

29
Q

What are the processes of angiogenesis vulnerable to antagonists?

A

VEGF antagonists –> VEGFR
ECM degradation, adhesion antagonists –> alphavbeta3 and MMPs
Endothelial cell antagonists –> Angiostatin, endostatin, thromobospondin-1

30
Q

What are the currently FDA approved drugs which target angiogenesis?

A

Avastin (Anti-VEGF Ab)
Sunitib (Blocks VEGFR signalling)
Pazopinib (Blocks VEGFR signalling)
Sorafenib (Blocks VEGFR signalling)

31
Q

Outline the animal trial of Sunitib?

A

Sunitib (SU11248) in Rat C6 glioma cells implanted in the colon of nude mice. Animals were treated with SU5416 or DMSO for 16 days. Day 16 tumours were quantified. 73% decrease in tumour volume

Refined structure –> Sunitib (SU11248)

32
Q

What is pazopanib used to treat?

A

metastatic renal cell carcinoma

33
Q

What is sorafenib used to treat?

A

Hepatocellular cancer and metastaic renal cell carcinoma

34
Q

What are the drugs in clinical trials that block activators of angiogenesis?

A

IgG fusion protein - VEGF-Trap
Small molecule inhibitors of VEGFR1 and VEGFR2
Small molecule inhibitors targeting Tie-2

35
Q

What is Marimastat?

A

A synthetic inhibitor of MMPs

36
Q

What is a drug in clinical trials that inhibits angiogenesis?

A

Endostatin

BS3003 (26 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions